| MWexperimental | 227 | kDa |
| MWexpected | 227 | kDa |
| VPorod | 1660 | nm3 |
|
log I(s)
1.50×10-1
1.50×10-2
1.50×10-3
1.50×10-4
|
s, nm-1
|
Zinc-finger protein CNBP alters the 3-D structure of lncRNA Braveheart in solution
Kim D, Thiel B, Mrozowich T, Hennelly S, Hofacker I, Patel T, Sanbonmatsu K, Nature Communications 11(1) (2020) DOISASDHK3 – Braveheart RNA + Cellular nucleic acid-binding protein (CNBP)
Braveheart RNACellular nucleic acid-binding protein
|
|
|
Fits and models
|
|
|
|
|
|
|
Synchrotron SAXS
data from solutions of
Braveheart RNA + Cellular nucleic acid-binding protein (CNBP)
in
50 mM HEPES-KOH, 100 mM KCl, 6 mM MgCl2, pH 7.6
were collected
on the
B21 beam line
at the Diamond Light Source storage ring
(Didcot, UK)
using a Pilatus 2M detector
at a sample-detector distance of 4 m and
at a wavelength of λ = 0.1 nm
(I(s) vs s, where s = 4πsinθ/λ, and 2θ is the scattering angle).
In-line size-exclusion chromatography (SEC) SAS was employed. The SEC parameters were as follows: A sample
at 0.9 mg/ml was injected
onto a column
.
620 successive
3 second frames were collected.
The data were normalized to the intensity of the transmitted beam and radially averaged; the scattering of the solvent-blank was subtracted.
This sample is the complex of Braveheart RNA and CNBP protein. SEC-column type and SEC parameters (flow-rate, injection volume) = UNKNOWN; Experimental temperature = UNKNOWN |
|
||||||||||||||||||||||||||||||||||||||||||||||||